Descrizione del progetto
Promuovere il coordinamento dell’infrastruttura ERINHA per gestire le malattie altamente infettive
Le epidemie del XXI secolo, dalla SARS all’Ebola e allo Zika, fino alla pandemia di COVID-19 e al vaiolo delle scimmie, hanno dimostrato la nostra vulnerabilità alle malattie altamente infettive a livello globale. Per la conduzione in sicurezza di ricerche sulle malattie altamente infettive è necessario l’accesso tempestivo a laboratori di contenimento elevato caratterizzati da un livello di biosicurezza (BSL, Biosafety Level) 3 e 4, ma queste strutture sono rare e costose. L’infrastruttura di ricerca europea sugli agenti altamente patogeni (ERINHA) è stata realizzata per consentire il coordinamento dei servizi di contenimento elevato nell’ambito della comunità scientifica, incluso l’accesso a strutture, competenze e formazione BSL3 e BSL4. Il progetto ERINHA-Advance, finanziato dall’UE, contribuirà alla sostenibilità a lungo termine degli sforzi di ERINHA, ampliando il numero dei suoi membri, migliorandone i servizi e affrontando episodi di malattia infettiva di interesse pubblico.
Obiettivo
One of the great challenges of the 21st century is to develop the capacity to prevent and react to outbreaks caused by highly pathogenic human and animal microorganisms, which are generally characterized by a high mortality rate, unavailability of prophylactics or effective therapeutic treatment and high human-to-human transmission.
ERINHA AISBL (European Research Infrastructure on Highly Pathogenic Agents), a pan-European Research Infrastructure (RI) dedicated to the study of high-consequence pathogens of Risk Group 4 (RG4), entered into implementation phase in July 2017. It now aims to ensure its long-term sustainability to better answer societal challenges in the field of Science, Health and Security.
The overall aim of the ERINHA-Advance project is to implement actions that will contribute to the long-term sustainability of the ERINHA RI, through enlargement of its membership and partnership and strengthening the overall services offer and framework by fostering the innovation potential of the RI.
To reach these goals, the RI will focus on the following specific objectives:
1. Enlarge ERINHA’s membership and research capacities (WP2);
2. Improve users services (WP3);
3. Stimulate the innovation potential of ERINHA and identify the co-innovation opportunities with industry (WP4);
4. Strengthen the overall services framework through long-term data-management and data sharing rules, clarification of IPR regimes and definition and implementation of the quality assurance system of the RI and its national nodes (WP5);
5. Reinforce ERINHA’s European and International cooperation with relevant countries, initiatives and networks (WP2 and WP6).
By achieving these objectives, ERINHA-Advance will largely contribute to providing access to larger number of high containment facilities to European and international scientists and foster research and innovation in the field of highly infectious diseases.
Campo scientifico
Parole chiave
Programma(i)
Argomento(i)
Invito a presentare proposte
Vedi altri progetti per questo bandoBando secondario
H2020-INFRADEV-2018-1
Meccanismo di finanziamento
RIA - Research and Innovation actionCoordinatore
1050 Bruxelles / Brussel
Belgio